- Revenue Cycle Management
- COVID-19
- Reimbursement
- Diabetes Awareness Month
- Risk Management
- Patient Retention
- Staffing
- Medical Economics® 100th Anniversary
- Coding and documentation
- Business of Endocrinology
- Telehealth
- Physicians Financial News
- Cybersecurity
- Cardiovascular Clinical Consult
- Locum Tenens, brought to you by LocumLife®
- Weight Management
- Business of Women's Health
- Practice Efficiency
- Finance and Wealth
- EHRs
- Remote Patient Monitoring
- Sponsored Webinars
- Medical Technology
- Billing and collections
- Acute Pain Management
- Exclusive Content
- Value-based Care
- Business of Pediatrics
- Concierge Medicine 2.0 by Castle Connolly Private Health Partners
- Practice Growth
- Concierge Medicine
- Business of Cardiology
- Implementing the Topcon Ocular Telehealth Platform
- Malpractice
- Influenza
- Sexual Health
- Chronic Conditions
- Technology
- Legal and Policy
- Money
- Opinion
- Vaccines
- Practice Management
- Patient Relations
- Careers
Patients are skeptical of AI in health care: a slideshow
Global survey finds some patients embrace innovations, but they are not a majority.
Not all patients want a computer analyzing their health.
Artificial intelligence (AI) has become one of the hottest issues in medicine, with numerous studies and news reports about the best ways to integrate it into health care.
But patients may not trust AI health innovations over human physicians who bring their education and experience into the examination room.
Global communications firm Edelman this month published its “2024 Edelman Trust Barometer Special Report: Trust and Health.” It has 55 pages of survey data from 16 countries around the world, with breakdowns by age, feelings of empowerment to make health decisions, and political leanings.
This slideshow has data about acceptance or rejection of AI health innovation. There are percentages for the United States, global average, and global high. All data come from Edelman.
Patient feelings were rated on a five-point scale. Patients who felt enthusiastic or passionate were rated as those who embrace innovation, while patients who were resistant or hesitant were classified as those rejecting the innovation, so the combined percentages may not total 100%.
The nations involved were Australia, Brazil, Canada, China, France, Germany, India, Japan, Mexico, Nigeria, Singapore, South Africa, South Korea, United Arab Emirates, the United Kingdom, and the United States.
